3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, B-Cell
2
Leukemia, Myeloid, Acute
2
Sarcoma, Ewing
1
Lymphoproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Interventions
X-Rays
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
trametinib
1
tazemetostat
1
palbociclib
1
olaparib
1
dabrafenib
1
Vemurafenib
1
Pharmacogenomic Variants
1
LY3023414
1
Genetic Testing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytosis, Langerhans-Cell
×
etoposide phosphate
×
30 days
×
Clear all
No trials found.